MedAssets Supply Chain Systems Selects STELLARATM, Patient Therapy Management Software from bioMérieux to Broaden Offering of Innovative Medical Technology
Atlanta, GA and Durham, NC (August 14, 2006) — MedAssets Supply Chain Systems and bioMérieux, Inc. are pleased to announce the first group purchasing agreement for STELLARATM, clinical intervention and patient therapy management software, powered by TheraDoc® Expert System Platform®.
Click
here to read the press release
STELLARA™ Demonstrates Significant Cost Savings and Reduction of Adverse Drug Events at Franciscan Health System
Durham, NC (February 13, 2006) — bioMérieux,
Inc. recently announced the one-year anniversary for STELLARA™
Clinical Intervention and Patient Monitoring software, powered
by TheraDoc® Expert System Platform®.
Click
here to read the press release
STELLARA™ Demonstrates Significant Cost Savings and Reduction of Adverse Drug Events After Only One Year of Implementation
LAS VEGAS, NV (December 5, 2005) —
bioMérieux, Inc. today announced the one-year anniversary
for STELLARA™ Clinical Intervention and Patient Monitoring
software launched at last year’s American Society of Health-System
Pharmacists (ASHP) forum in Orlando.
Click
here to read the press release
bioMérieux Releases Full Capabilities of STELLARA™
Clinical Management System: Étage 4 is Now Available
DURHAM, N.C. (June 30, 2005 ) — bioMérieux, Inc. announced the availability of the fourth performance level (Étage 4) for its STELLARA Clinical Intervention and Patient Monitoring software. The STELLARA system provides knowledge-enriched, infectious disease-specific recommendations to clinicians for medication treatment management.
Click
here to read the press release
bioMérieux Launches Intelligent Patient Therapy Management Solution
STELLARA™ Improves Patient Safety and Treatment Cost Management
DURHAM, N.C. (December 9, 2004) — bioMérieux,
Inc. today announced the launch of its STELLARA™ Clinical
Intervention and Patient Monitoring software at the American
Society of Health-System Pharmacists (ASHP) forum in Orlando,
Florida.
Click
here to read the press release
bioMérieux and TheraDoc Enter
Exclusive Agreement for STELLARA™,
a Real-time Clinical Intervention Software System
Durham, North Carolina (April 2004) –
bioMérieux, Inc., is pleased to announce that it has
entered an industry exclusive agreement with TheraDoc®,
Inc., allowing bioMérieux to market a comprehensive new
suite of STELLARA™ real-time clinical-intervention software
systems. The new systems bring the microbiology results (identification/
susceptibility/resistance) from bioMérieux’s leading
BacT/ALERT® and VITEK® systems
directly to the pharmacist and clinician – in real time
– to support quicker actionable results.
Click
here to read the press release
|
